Accession Number: | 0001209191-19-025296 |
Date: | 2019-04-16 |
Issuer: | GENOMIC HEALTH INC (GHDX) |
Original Submission Date: |
FLANNELLY BARRY P
1801 AUGUSTINE CUT-OFF
WILMINGTON, DE 19803
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
DIRECTOR STOCK OPTION (RIGHT TO BUY) | 65.2 | 2019-04-16 | deemed execution date | A | 20,000 (a) | 2029-04-16 | common stock 0 | $65.20 | 20,000 | direct |
ID | footnote |
---|---|
f1 | the option becomes exercisable as to 25% of the shares on april 16, 2020, and becomes exercisable as to 1/48th of the shares each full month thereafter. |